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ABSTRACT
Background: Pancreatic fistula (PF) is a major source of morbidity following distal
pancreatectomy (DP). Our aim was to identify risk factors related to PF following DP and to
determine the impact of technique of transection and stump closure.
Methods: We performed a retrospective review of 215 consecutive patients who underwent DP.
Perioperative and postoperative data were collected and analyzed with attention to PF as defined
by the International Study Group of Pancreatic Fistula (ISGPF).
Results: PF developed in 36 patients (16.7%); fistulas were classified as Grade A (44.4%), B
(44.4%), or C (11.1%). The pancreas was transected with stapler (n=139), cautery (n= 70) and
scalpel (n= 3). PF developed in 19.8% of remnants which were stapled/oversewn and 27.7% that
were stapled alone (p=0.4). Of the 69 pancreatic remnants transected with cautery and
oversewn, a fistula developed in 4.3% (p=0.004 compared to stapled/oversewn; p=0.006
compared to stapled/not sewn). The median length of post-operative hospital stay was
significantly increased in patients who developed PF (10 vs. 6 days, p=0.002)
Conclusion: The method of transection and management of the pancreatic remnant plays a
critical role in the formation of PF following DP. This series suggests that transection using
electrocautery followed by oversewing of the pancreatic remnant has the lowest risk of PF.
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INTRODUCTION
Distal pancreatectomy (DP) is the procedure of choice for benign or malignant lesions in
the pancreatic body or tail. The typical procedure consists of resection of the pancreatic
parenchyma at a variable point to the left of the superior mesenteric vein-portal vein axis, and
may include concomitant removal of the spleen. For decades, DP had been associated with high
morbidity and low but measurable mortality. In recent years, the mortality rate after DP has been
reduced to less than five percent in high volume centers1-5, however morbidity rates remain high
ranging from 10-47%3,6-8. Pancreatic fistula is the most frequently reported complication and the
primary cause of post-operative morbidity following DP6-10. Development of pancreatic fistula
often leads to further complications such as intra-abdominal abscess, sepsis, hemorrhage,
delayed gastric emptying, and occasionally malabsorption. These additional complications have
important implications for the healthcare system, often with additional procedures, increased
length of hospital stay and increased cost9-11.
While it is clear that pancreatic fistula remains a problem following DP, the risk factors
for development of fistula are not well defined. Obesity, patient age, trauma, malignancy, duct
obstruction and texture of the pancreatic parenchyma have all been implicated as potential risk
factors9,12. However, surgical technique is also considered an important risk factor for the
development of pancreatic fistula9. A wide variety of surgical techniques for parenchymal
transection and closure of the pancreatic remnant have been described in an effort to reduce the
occurrence of fistula. These techniques include stapled closures, sutured closures, combined
stapled and sutured closures, ultrasonic dissection, sealing with fibrin glue, application of mesh,
seromuscular flaps, pancreaticoenteric anastomosis and ligation of the main pancreatic duct at
the transection line3,6-9,11-21. Currently, there is no consensus as to the optimal surgical technique
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for pancreatic transection and stump closure during distal pancreatectomy. The purpose of this
study is to determine the impact of the type of pancreatic transection and closure of the
pancreatic remnant on the formation of pancreatic fistula.
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MATERIAL AND METHODS
Our Institutional Review Board approved this retrospective review of all patients who
underwent distal pancreatectomy at Thomas Jefferson University Hospital from January 1996
through July 2008. Patients who underwent distal pancreatectomy were identified using
electronic search of a surgical database. The indications for distal pancreatectomy included
primary pancreatic processes, non-pancreatic malignancies and trauma. No patients were
excluded from the study. Octreotide was rarely used in the preoperative, prophylactic
setting, but was often used in patients with documented pancreatic fistulae.
Patient data including demographics, comorbidities, additional procedures, method of
pancreatic transection, management of the pancreatic remnant, operative time, blood loss,
pathology, and post-operative complications were collected using hospital electronic record and
chart review. These data were compiled and further analyzed. The primary endpoint was
pancreatic fistula. Pancreatic fistula was defined using the International Study Group on
Pancreatic Fistula (ISGPF) definition: drainage of any measurable volume after post-operative
day 3, with an amylase content of greater than three times the normal serum value22. Pancreatic
fistulas were retrospectively graded according to the ISGPF grading system22. Secondary
endpoints were all complications.
Statistical Analysis
Continuous variables (such as length of post-operative hospital stay) were compared
using a two-sided Student’s t-test. Qualitative variables (such as pancreatic fistula rates) were
compared using Fisher’s exact test. Bivariate crosstabulations, with Chi-square statistics, to
assess bivariate associations between selected risk factors and the occurrence of fistulas were
performed. A multivariate logistic regression analysis which modeled the occurrence of fistulas
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as a function of all risk factors with significant bivariate associations and also selected other
variables (i.e., age group, sex, body mass index, and estimated blood loss) to assess and control
for confounding was performed. A p-value less than 0.05 was considered significant. SAS
Release 9.2 statistical software (SAS Institute, Inc., Cary, NC) was used for all analyses.
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RESULTS
From January 1996 to July 2008, 215 patients underwent distal pancreatectomy. There
were more females (n=125; 58%) than males (n=90; 42%). The mean age of patients was 58.8
years (range, 18-87 years). Indications for distal pancreatectomy are listed in Table 1. More
patients were operated on for benign lesions (61%) than for malignancies (39%). The most
frequent benign lesions were cystadenomas (12.6%), intra-ductal papillary mucinous neoplasms
(IPMN; 9.8%), and neuroendocrine tumors (9.8%). Eight patients (3.7%) underwent distal
pancreatectomy for pancreatic trauma. Of the malignant lesions, pancreatic ductal
adenocarcinoma (19%) and neuroendocrine tumors (9.8%) were the most frequent indications.
Open distal pancreatectomy with splenectomy was performed in 84% of patients (Table
2). Open distal pancreatectomy with splenic preservation was performed in 9%. Laparoscopic
resection was attempted in 16 patients (7.4%) and completed in 13 patients (6%). Additional
organs, excluding the spleen, were resected in 108 patients (50%); the majority of these were
incidental cholecystectomies (Table 3). The mean operative time was 274 minutes (range 83665) and the average blood loss was 621 milliliters (range 0-5400). The pancreas was transected
using a stapler in 139 patients, electrocautery in 70 patients, and scalpel in 3 patients (unknown
in 3 patients) (Figure 1). Of the 139 patients who were transected with stapler, the pancreatic
remnant was oversewn in 91 patients, not oversewn in 47 patients, and sealed with tissue glue in
one patient. Of the 70 patients who were transected with electrocautery, the pancreatic remnant
was oversewn in 69 patients and not oversewn in one patient. For the 3 patients who were
transected with scalpel, the remnant was oversewn in one patient, not oversewn in one patient,
and pancreatico-jejunostomy was performed in one patient.
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Pancreatic fistula was the most common complication, occurring in 36 patients (16.7%).
Pancreatic fistula occurred in 50% of patients undergoing laparoscopic spleen preserving
distal pancreatectomy, 44.4% of patients undergoing laparoscopic distal pancreatectomy
and splenectomy, 15.6% of patients undergoing open distal pancreatectomy and
splenectomy, and 10.0% of patients undergoing open spleen preserving distal
pancreatectomy. The characteristics of patients who developed a pancreatic fistula are
described in Table 4. Fistulas were classified as Grade A in 16 patients (44.4%), Grade B in 16
patients (44.4%), and Grade C in 4 patients (11.1%). Pancreatic fistula developed in 27.7% of
patients that were stapled and not oversewn, 19.8% of patients where the remnants were stapled
and oversewn, and only in 4.3% of remnants that were divided by cautery and oversewn (Figure
1). The fistula rate for remnants that were cauterized and oversewn was significantly lower as
compared to the leak rate in both stapled and oversewn (p=0.004) and stapled and not oversewn
(p=0.0006). There was no difference in the incidence of pancreatic fistula between patients
who had additional organs (excluding spleen) resected compared to those where no
additional organs were resected (13% vs. 20.6%; p=0.15). Of the 13 laparoscopic cases (all
stapled and none oversewn), six (46.2%) developed pancreatic fistula.
The median length of post-operative hospital stay was significantly increased in patients
who developed pancreatic fistula, as compared to those who did not develop a fistula (10 days
versus 6 days; p=0.002) (Table 4). Pancreatic fistula was treated with maintenance of JP
drainage alone in 41.7% of patients and maintenance of JP drainage plus octreotide in 30.6% of
patients. Percutaneous drain placement by interventional radiology was required in 22.2% of
fistulas. Three patients who developed fistula required re-operation; all three had Grade C
fistulas.

9

Fifty-five patients (25.6%) developed at least one post-operative complication (Table 5).
There were two peri-operative deaths (0.9%). One was a patient with malignant
pheochromocytoma adherent to the pancreas and spleen, who developed post-operative sepsis
and multi-system organ failure (death on post-operative day #48). The other mortality was a
patient with metastatic melanoma who expired from unexpected cardiac arrest in the postoperative period (death on post-operative day # 21).
We also examined fistula rates based on surgical volume at the entire institution. As
one can see from Figure 2, the volume of pancreatic surgery increased by several-fold
beginning in 2006. Prior to this point, there were a total of 93 distal pancreatectomies,
while starting in 2006, there were a total of 120 distal pancreatic resections. When
calculating leak rates pre- and post-2006, there is a significant decrease in leak rates (26%
vs. 10%, p=0.003).
Bivariate analyses showed that pancreatic transection using a stapler, not oversewing the
pancreatic remnant, and low surgeon volume (fewer than 20 total cases performed) were all
significantly associated with the development of pancreatic fistula (Table 6). While the bivariate
analyses show significant differences in the likelihood of a pancreatic fistula, as noted, none of
these differences remained significant in the multivariate logistic regression analysis (Table 7),
although the method of pancreatic transaction was borderline significant (p=0.058) with a hazard
ratio of 3.2.
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DISCUSSION
In the present study, we analyzed the morbidity and mortality associated with DP, with
particular attention to pancreatic fistula and surgical technique. For the 215 patients in this
series, we report a mortality rate of 0.9% and a morbidity rate of 25.6%. Pancreatic fistula was
the most frequent complication, occurring in 16.7% of patients. We found a significantly lower
fistula rate in pancreatic remnants that were transected by cautery and oversewn (4.3%), as
compared to remnants that were stapled and oversewn (19.8%; p=0.004) or stapled and not
oversewn (27.7%; p=0.0006). In our relatively small laparoscopic group, 46.2% developed
pancreatic fistula. Median length of stay was significantly increased in patients who developed
pancreatic fistula compared to those who did not (10 days versus 6 days; p=0.002).
Our data support the claim that DP can be performed with low mortality1-5, however,
morbidity remains high largely due to pancreatic fistula. Our pancreatic fistula rate falls within
the range of 3-26% reported in the literature3,6-8. This wide variability of fistula rates is likely
due to discrepancy in the diagnostic criteria used to define pancreatic fistula across the various
studies. A review by Bassi et al identified more than 25 definitions of pancreatic fistula that vary
based on the daily amount of drain output, amylase level of the fluid and duration of drainage23.
In this study, pancreatic leaks were defined and classified according to the standard definitions
outlined by the ISGPF.22 Pancreatic fistula was defined as a drain output of any measurable
volume of fluid on or after post-operative day three with an amylase content greater than three
times the serum amylase content. Grade A fistulas, or “transient fistulas”, have little clinical
impact. Grade B fistulas require a change in management, usually have persistent drainage after
three weeks and may be associated with signs of infections. Grade C fistulas are associated with
a major change in clinical pathway and patient stability may be borderline. The ISGPF
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definition has resulted in an internationally accepted standard definition of pancreatic fistula that
allows for better comparisons between fistula rates from different institutions. Using the ISGPF
definition, our pancreatic fistula rate of 16.7% falls in the middle of the range of reported rates in
the literature. Given the fact that the ISGPF definition was not published until 2005, many leaks
were identified and graded in a retrospective fashion by reviewing inpatient medical records.
Management of pancreatic fistula following DP has not been standardized. The majority
of the pancreatic fistulas that occurred in our series were either Grade A or Grade B. All of these
were managed conservatively. Intra-operatively placed drains were maintained and additional
percutaneous drains were placed when necessary for undrained collections. Octreotide was
administered to patients at the discretion of the surgeon. Patients were additionally supported
with parenteral nutrition when indicated. Most patients had a delay in hospital discharge as a
result of their fistula. With conservative management, all Grade A and B fistulas closed
spontaneously. Four Grade C fistulas occurred in our study. Three of these required reoperation
for either hemorrhage or abdominal sepsis. Mortality occurred in two patients with Grade C
fistulas; both of these patients had malignant tumors with metastatic disease. The increased
utilization of healthcare resources and potential severity of disease associated with pancreatic
fistula illustrates the need for effective methods to reduce their incidence.
The optimal surgical technique for both pancreatic transection and closure of the
pancreatic remnant remains a debate. A multitude of surgical techniques and instruments have
been proposed for reducing the occurrence of pancreatic fistula. A partial list of techniques
includes hand-sutured closure, stapled closure, sutured plus stapled closure, sealing with fibrin
glue, application of mesh, seromuscular flaps, ultrasonic dissection, bipolar scissors,
pancreaticoenteric anastomosis and ligation of the main pancreatic duct3,6-9,11-21. The most
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frequently used techniques are the suture and stapler closures of the pancreatic remnant. Kleeff
et al have observed a significantly increased risk of pancreatic fistula with stapled closure9. In
contrast, other investigators have reported increased pancreatic fistula rates with sutured closure
of the pancreatic remnant3,14,15,24. Many have concluded that the method of stump closure has no
impact on the incidence of pancreatic fistula12,13,21,25,26.
In our study, the surgical technique most commonly involved transection of the
pancreatic parenchyma with a stapler or electrocautery. The pancreatic remnant was then either
oversewn or not oversewn at the discretion of the attending surgeon. We found a significantly
lower fistula rate in pancreatic remnants that were cauterized and oversewn (4.3%), as compared
to remnants that were stapled and oversewn (19.8%; p=0.004) or stapled and not oversewn
(27.7%; p=0.0006). Bivariate analysis confirmed the importance of method of transaction
(p=0.012), type of remnant closure/sealing (p=0.012), and surgeon volume (p<0.001) for
pancreatic fistula after distal pancreatectomy. Multivariate analysis failed to demonstrate one
single independent factor, although the method of pancreatic transection showed a nearly
significant increase in risk of fistula (p=0.058, hazard ratio=3.2) with the use of non-stapled
transection. It is likely that if there were more patients in our study, that this factor would have
reached statistical significance.
Interestingly, surgeon volume was a significant factor in the determination of pancreatic
fistula. We used a cutoff of <20 procedures during the period of this study. This left us with
groups that were relatively equal in size. There were a total of 24 surgeons who performed distal
pancratectomies in this series, with a volume range of one to 67. The median number of cases
performed was 2.5, and there were three surgeons who performed more than 20 procedures with
a leak rate of 10% in the high volume group, as compared to 28% for the lower volume surgeons.
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This factor was not, however, significant on multivariate analysis. Surgeon volume has not been
thoroughly examined as a specific risk factor for pancreatic fistula after pancreatic resection, and
in fact, ours is the first one that we could find that addressed its potential importance for leaks
after distal pancreatectomy. Another fact that we found to be significant was institutional
volume. Starting at the beginning of 2006, there was a dramatic increase in the number of
pancreatic resections performed. In 2006, 2007, and half of 2008, there were a total of 120
distal pancreatectomies a year (mean=40 per year), while in the prior years of the study,
there were 93 distal resections (mean=9.5). As one would expect, the increased institutional
volume lead to a significant decrease in the number of pancreatic fistulae (26% vs. 10%,
p=0.003).
Several authors state that the texture of the pancreatic parenchyma is an important risk
factor associated with the development of post-operative pancreatic fistula.3,12,13 Fibrotic
pancreatic tissue is believed to be less likely to leak as compared to soft pancreatic parenchymal
tissue, as long as the continuity of the main pancreatic duct is not compromised. Due to the
retrospective nature of our study, we were unable to include pancreatic texture as a variable in
our analysis as we found that it was not consistently reported in the operative reports and medical
records that were reviewed.
The administration of prophylactic octreotide to reduce the incidence of postoperative pancreatic fistula remains controversial. Several studies have shown that
prophylactic octreotide reduces the rate of pancreatic fistula following elective pancreatic
resection.27-30 In contrast, other authors have shown no benefit to the use of prophylactic
octreotide.31,32 Prophylactic octreotide was not included as a variable in our study. The
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retrospective nature of our study precluded its use as a variable for analysis, as we found
that it was not consistently reported in the reviewed medical records.
Laparoscopic surgery has quickly been adopted as the standard for a variety of solid
organ resections. In the surgical treatment of pancreatic disease, laparoscopic resections are
becoming increasingly popular. To date, most reports of laparoscopic distal pancreatectomy are
small series from single institutions.33-38 The occurrence of pancreatic fistula following
laparoscopic distal pancreatectomy in these studies has been reported as ranging from 13-50%.3338

A large, multi-center retrospective reviewe comparing laparoscopic distal

pancreatectomy with open distal pancreatectomy reported shorter length of hospital stay
with laparoscopic distal pancreatectomy and no significant differences in major
complication rate or pancreatic fistula rate when compared to open distal
pancreatectomy.39 In our series, laparoscopic distal pancreatectomy was attempted in 16
patients and completed in 13 patients. Pancreatic fistula occurred in 6 (42.6%) of these 13
patients. This fistula rate is at the higher end of the reported ranges in the literature. We expect
that as this technique becomes more widely used and newer techniques are developed, the
incidence of pancreatic fistula will decrease.
Our institution has recently opened a randomized, prospective clinical trial evaluating the
method of pancreatic stump closure following distal pancreatectomy (NCT00889213). In this
trial, patients are stratified by pancreatic texture and randomized to one of two methods of
closure—standard closure (investigator’s choice of stapler, cautery or sharp transaction with
suture closure at surgeon’s discretion) or experimental closure which adds an autologous
falciform patch and the placement of fibrin glue (Vitagel) between the parenchyma and the
patch. This trial began accruing patients in August 2008 and has an accrual goal of 190 patients.
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We hope that this trial will help to resolve the controversy around management of the pancreatic
stump after distal pancreatectomy.
In summary, pancreatic fistula remains a significant cause of the morbidity associated
with distal pancreatectomy. The method of transection of the pancreatic parenchyma and
management of the pancreatic remnant appear to be related to the formation of pancreatic fistula.
This series suggests that transection using electrocautery followed by oversewing of the
pancreatic remnant minimizes the formation of pancreatic fistula. Additional prospective,
randomized studies are needed in order to determine the optimal surgical technique for
parenchymal transection and remnant closure during distal pancreatectomy to minimize the
occurrence of post-operative pancreatic fistula.
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Table 1. Indications for distal pancreatectomy.
Indications for Distal Pancreatectomy
(n=215 patients)
# (%) of
patients
Benign
Cystadenoma (serous and mucinous)
IPMN
Neuroendocrine
Solid Pseudopapillary Neoplasm
Pseudocyst
Trauma
Chronic Pancreatitis
Cysts
Microcystic Adenoma
Abscess
Pancreatic Intraepithelial Neoplasia
Inflammatory Myofibroblastic Tumor
Miscellaneous
Total Benign
Malignant
Ductal Adenocarcinoma
Neuroendocrine
Metastatic Tumors
Mucinous Cystadenocarcinoma
Gastric Cancer
Adenosquamous Carcinoma
Anaplastic Carcinoma
Acinar Cell Carcinoma
Lymphoma
Liposarcoma
Total Malignant

27 (12.6)
21 (9.8)
21 (9.8)
13 (6.0)
8 (3.7)
8 (3.7)
7 (3.3)
7 (3.3)
6 (2.8)
2 (0.9)
2 (0.9)
1 (0.5)
9 (4.2)
132 (61%)

41 (19.0)
21 (9.8)
8 (3.7)
3 (1.4)
3 (1.4)
2 (0.9)
2 (0.9)
1 (0.5)
1 (0.5)
1 (0.5)
83 (39%)

22

Table 2. Demographics and clinical characteristics.
Demographic and Clinical Characteristics
(Total=215 patients)
Mean Age in years (range)
58.8 (18-87)
Female
Male
Race
Caucasian
African American
Hispanic
Other
Mean Body Mass Index (range)
Procedure
Open distal pancreatectomy and
splenectomy
Open distal pancreatectomy (spleen
preserving)
Laparoscopic distal pancreatectomy
and splenectomy
Laparoscopic distal pancreatectomy
(spleen preserving)
Open subtotal pancreatectomy

125 (58%)
90 (42%)

194 (90.2%)
13 (6.0%)
3 (1.4%)
5 (2.3%)
26.9 (16.4-60.1)

180 (83.7%)
20 (9.3%)
9 (4.2%)
4 (1.9%)
2 (0.9%)

Patients with additional organs resected

108 (50.2%)

Mean operative time in minutes (range)

274 (83-665)

Mean blood loss in milliliters (range)

621 (0-5400)

Median length of post-operative hospital
stay in days (range)

6 (2-61)
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Table 3. Additional operative procedures performed.
Additional Operative Procedures*
Cholecystectomy
Gastrectomy
Partial colectomy
Wedge resection of liver
Nephrectomy
Adrenalectomy
Small bowel resection
Hysterectomy and bilateral salpingo-oophorectomy
Oophorectomy
Resection of omental mass
Orthotopic liver transplant
Pancreaticojejunostomy
Resection of retroperitoneal mass
*Some patients had more than one additional procedure

No. (%) of Patients
66 (30.1)
22 (10.2)
10 (4.7)
8 (3.7)
8 (3.7)
6 (2.8)
3 (1.4)
2 (0.9)
1 (0.5)
1 (0.5)
1 (0.5)
1 (0.5)
1 (0.5)
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Table 4. Characteristics of patients with pancreatic fistula.
Clinical Characteristics of Patients with Pancreatic Fistula
(n=36)
Mean age years (range)

53.8 (21-77)

Gender
Female
Male

20 (55.6%)
16 (44.4%)

Mean Body Mass Index (range)
Procedure
Open distal pancreatectomy and
splenectomy
Open distal pancreatectomy (spleen
preserving)
Laparoscopic distal pancreatectomy
and splenectomy
Laparoscopic distal pancreatectomy
(spleen preserving)

26.5 (17.9-43)

28 (77.8%)
2 (5.6%)
4 (11.1%)
2 (5.6%)

Additional organs resected

14 (39%)

Median length of post-operative
hospital stay days (range)

10 (4-61)

Grade of Fistula
Grade A
Grade B
Grade C

16 (44.4%)
16 (44.4%)
4 (11.1%)

Management of Fistula
JP drain alone
JP drain + octreotide
Interventional radiology drainage
Endoscopic cystgastrostomy
Re-operation

15 (41.7%)
11 (30.6%)
8 (22.2%)
1 (2.8%)
3 (8.3%)
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Table 5. Post-operative complications.
All Post-operative Complications
(Total patients=215)
Pancreatic fistula
Intra-abdominal abscess
Small bowel obstruction
Respiratory
Cardiac
Sepsis
Wound Infection
Delayed gastric emptying
Mortality
Patients with complication
Patients without complication

# of patients (%)
36 (16.7)
22 (10.2)
8 (3.7)
6 (2.8)
5 (2.3)
4 (1.9)
3 (1.4)
2 (0.9)
2 (0.9)
55 (25.6)
160 (74.4)
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Table 6. Bivariate Analysis
Bivariate Analysis: Proportion of cases with pancreatic fistula by selected risk factors
Method of pancreatic
transection
Method of sealing
pancreatic remnant

Not stapled

Stapled

4/73=5.48%

31/139=22.30%

Oversewn

Not oversewn

21/161=13.04%

15/54=27.78%

High

Low

14/136=10.29%

22/79=27.85%

Surgeon volume

Chi-square=9.83, df=1,
p=0.002
Chi-square=6.30, df=1,
p=0.012
Chi-square=11.05, df=1,
p<.001

27

Table 7. Multivariate Logistic Regression Analysis
Multivariate Logistic Regression Analysis
Variable

Effect

Odds
Ratio

95%
LCL

95%
UCL

df

Wald
X2

p-value

Age

50-59 vs. 18-49
60-69 vs. 18-49
70+ vs. 18-49

0.565
0.524
0.521

0.188
0.175
0.174

1.696
1.564
1.563

3

2.0570

0.5607

Gender

Male vs. Female

1.137

0.485

2.666

1

0.0870

0.7680

Body Mass Index

25-29.99 vs.<25
>=30 vs. <25

1.238
0.658

0.498
0.237

3.081
1.825

2

1.3065

0.5203

Estimated Blood
Loss

200-499 vs. <200
500-799 vs. <200
800+ vs. <200

2.023
1.744
1.407

0.684
0.440
0.395

5.981
6.903
5.014

3

1.7330

0.6296

3.242

0.962

10.928

1

3.5980

0.0578

Method of
pancreatic
transection

Stapled vs. Nonstapled

Method of sealing
pancreatic remnant

Not oversewn vs.
Oversewn

1.570

0.669

3.686

1

1.0744

0.2999

Surgeon volume

Low vs. High

1.881

0.785

4.510

1

2.0066

0.1566
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Figure 1.
Method of
Transection

Stapler
(n=139)

Electrocautery
(n=70)

Scalpel
(n=3)

Management
of Remnant

Oversewn
(n=91)

Not Sewn
(n=47)

Tissue Glue
(n=1)

Oversewn
(n=69)

Not Sewn
(n=1)

Oversewn
(n=1)

Not Sewn
(n=1)

P-J
(n=1)

Pancreatic Fistula
Rate

n=18
(19.8%)

n=13
(27.7%)

n=0
(0.0%)

n=3
(4.3%)

n=1
(100.0%)

n=0
(0.0%)

n=0
(0.0%)

n=0
(0.0%)

*
**
P-J=pancreaticojejunostomy, *p=0.0006, **p=0.004

Figure 1 Legend—Flowsheet demonstrating the breakdown of patients by method of transection
of pancreatic remnant, management of the remnant, and fistula rates.

Figure 2.
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Graph demonstrating increasing volume of distal pancreatectomies by year at Thomas Jefferson
University Hospital.
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